Biotechnology

TotalEnergies ENEOS Signs Solar Rooftop Project with Ecolite, a health and wellness company in Malaysia

KUALA LUMPUR, Malaysia, Feb. 2, 2023 /PRNewswire/ -- Ecolite Biotech Manufacturing Sdn Bhd, a health and wellness company inMalaysia, has signed a long-term agreement with TotalEnergies ENEOS to provide a 0.4 megawatt-peak (MWp) solar photovoltaic (PV) system to its facility inMalaysia. Ecolite i...

2023-02-02 10:00 1481

Invivoscribe Appoints Masato Sasaki as General Manager of LabPMM, GK (Japan)

SAN DIEGO, Feb. 2, 2023 /PRNewswire/ -- Invivoscribe is pleased to announce the appointment ofMasato Sasaki as General Manager of LabPMM GK, our reference laboratory inJapan. Mr. Sasaki brings a wealth of scientific experience with him as he served at Illumina K.K. (Japan) as a leader on their cl...

2023-02-02 05:00 1054

Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers

HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Feb. 1, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that it is advancing the clinical development of...

2023-02-01 15:00 1136

Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic

HONG KONG, Jan. 31, 2023 /PRNewswire/ -- In response to the infection peak season of COVID-19 in rural areas that may be brought about by people returning home during Chinese New Year, Fosun Foundation announced on9 January 2023 the cooperation with Fosun Pharma and Genuine Biotech to donateRMB10...

2023-01-31 16:10 1525

Daewoong enters exclusive licensing agreement with CS Pharmaceuticals for Bersiporocin in Idiopathic Pulmonary Fibrosis in the Greater China Region

* Daewoong Pharmaceutical to receive up to $76M upfront and development milestone payment plus a double-digit royalties on Net Sales * CS Pharmaceuticals will receive exclusive rights for development and commercialization of Bersiporocin for the treatment of IPF and other respiratory indica...

2023-01-31 14:43 1196

Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 3 Clinical Trials of Ecnoglutide (XW003), a Long-acting GLP-1 analog, for the Treatment of Type 2 Diabetes in China

HANGZHOU, China and SAN FRANCISCO, Jan. 31, 2023 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, announced today the initiation of patient dosing in Phase 3 clinical tr...

2023-01-31 08:00 1099

Novotech Awarded by Frost & Sullivan for Global Biotech Clinical Trials Excellence in APAC

With a proven biotech market leadership position, Novotech's compelling value proposition drives its sustained success in delivering biotech clinical trials. SAN ANTONIO, Jan. 31, 2023 /PRNewswire/ -- Frost & Sullivan recently analyzed theAsia-Pacific contract research organization industry and, ...

2023-01-31 05:37 1233

Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer

* ESR1 mutations are present in up to 40% of ER+, HER2- advanced or metastatic breast cancers. * ESR1 mutations are a known driver of resistance to standard endocrine therapy, and so far, have been difficult to treat. * ORSERDU is the first endocrine innovation in more than 20 years, specif...

2023-01-30 20:39 1561

Duoning Headquarters in Fengxian Biotechnology Park with Centers for R&D and Technology Applications

SHANGHAI, Jan. 30, 2023 /PRNewswire/ -- Shanghai Duoning Biotechnology Co., Ltd. ("Duoning") announced that the company signed an Agreement on theTransfer of the Right to Use State-owned Construction Land with the Bureau of Planning and Natural Resources of Fengxian District,Shanghai and official...

2023-01-30 18:00 1457

MGI Makes its Mark in Dubai with Latest Platforms at MEDLAB Middle East and Arab Health

DUBAI, UAE, Jan. 30, 2023 /PRNewswire/ --  MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, will introduce many of its latest gene sequencing platforms and sample preparation system at MEDLAB Middle East 2023, ...

2023-01-30 16:00 1113

Kalbe Consumer Health Crowned Winner at the Asia Pacific Enterprise Awards 2022 Regional Edition

SINGAPORE, Jan. 27, 2023 /PRNewswire/ -- Enterprise Asia, the organizer of the Asia Pacific Enterprise Awards (APEA) 2022 Regional Edition, is pleased to recognize 25 exemplary business leaders and enterprises acrossAsia which excelled and showcased unparalleled resilience and growth despite theC...

2023-01-30 11:26 1622

Abbisko Therapeutics announces that US FDA has granted breakthrough therapy designation for its CSF-1R inhibitor Pimicotinib(ABSK021)

SHANGHAI, Jan. 30, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) today announced that its CSF-1R inhibitor Pimicotinib(ABSK021)has been granted the breakthrough therapy designation from FDA for the treatment of tenosynovial giant cell tumor (TGCT) patients...

2023-01-30 11:00 1492

DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease

SALT LAKE CITY, Jan. 27, 2023 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the U.S. Food and Drug ...

2023-01-27 08:46 2392

Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication by China NMPA

--Preclinical studies show that ASC10-A, the active metabolite of double prodrug ASC10, has potent antiviral activities against both monkeypox and SARS-CoV-2 viruses --Ascletis has received the Notice of Issuance from the United States Patent and Trademark Office (USPTO) for the patent applicati...

2023-01-26 21:08 2015

GenKOre Announces Collaboration with a US-based Company on In vivo Gene-editing Therapy

SEOUL, South Korea, Jan. 26, 2023 /PRNewswire/ -- GenKOre, Inc., a Korea-based biotech company with hypercompact CRISPR-Cas tools, announced that it has entered into a strategic research collaboration with a US-based biopharma company for the development of in vivo  gene editing therapies. This c...

2023-01-26 09:00 2052

PlumCare RWE partners with Lifebit on Greece's newborn genomic sequencing program, BeginNGS

* PlumCare RWE and Lifebit enter a three-year partnership to support Greece's pioneering national newborn genomic sequencing program, BeginNGS. * Researchers will be able to access and analyse data securely in combination with global cohorts, whilst ensuring data is kept safe, private and in p...

2023-01-25 23:00 1993

IVI opens Country Office in Austria

SEOUL, South Korea, Jan. 25, 2023 /PRNewswire/ -- The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, announced today the launch of an IVI Count...

2023-01-25 11:17 1622

DiscGenics Announces Positive Two-Year Clinical Data from U.S. Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

Discogenic progenitor cell therapy safely increased disc volume and provided rapid, durable improvements in low back pain, function, quality of life, and pain medication usage out to two years post-injection in patients with lumbar DDD. SALT LAKE CITY, Jan. 25, 2023 /PRNewswire/ -- DiscGenics, I...

2023-01-25 08:35 1647

Seragon Announces RESTORIN®, the Most Advanced Anti-Aging Nutraceutical to Date

IRVINE, Calif., Jan. 19, 2023 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the launch of RESTORIN®, an advanced nutraceutical for healthy aging. RESTORIN integrates a series of patented technologies fromHarvard University, Mayo Clinic, and Scripps Research to boost cellular nicotinam...

2023-01-19 23:10 2861

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun Pharma's Global Infrastructure to Provide Broad Access to Deuruxolitinib for Patients with Alopecia Areata Strengthens Sun Pharma's Global De...

2023-01-19 23:05 3007
12345 ... 141